

How protein took over the supermarket

The most talked-about drug class began with a desert lizard

GLP-1 drugs cut food noise in half, but clinicians warn hunger cues remain essential

When a parent’s body changes, children notice


GLP-1 use for weight loss nearly quadrupled in two years

A 2026 national survey found that 11% of adults reported currently using a GLP-1 medicine for weight loss

GLP-1 medicines joined America's long weight-loss history instead of replacing it


Triple-Target Incretin Drug Kills Knee Osteoarthritis Pain in Obesity
In the 68-week TRIUMPH-4 trial of 445 patients with obesity and knee osteoarthritis, weekly retatrutide injections cut WOMAC pain scores by over 4.4 points versus 2.43 with placebo. Targeting GLP-1, GIP, and glucagon receptors, the drug helped participants shed over a quarter of their body weight despite substantial baseline joint damage.
GLP-1s confer better glycemic, CV outcomes than metformin

Los medicamentos GLP-1 pueden ayudar a revertir la prediabetes, según un estudio

Incretin Drug May Improve Menstrual Regularity

Menopausal Hormone Therapy May Boost GLP-1 Weight Loss


A GLP-1 medicine is being tested against methamphetamine addiction
Researchers at the University of Texas Southwestern have completed a pilot study of tirzepatide in adults who have both obesity and moderate to severe methamphetamine use disorder. The study planned for up to 45 participants. Everyone received the medicine once a week for 32 weeks, prescribed for its approved weight use, with weekly clinic visits and a four-week follow-up. The phase 2 study had no comparison group; it was built to test whether such a trial is feasible and to look for early signs of an effect.
A designed enzyme shows where protein engineering is heading

A GLP-1 implant is testing a different delivery idea, not offering a new option yet

The cancer question around GLP-1 medicines is still early

Protein design is expanding the research toolkit behind future medicines




